5 July 2015

Plethora treatment wins NHS approval

15/04/2011 Ben Jaglom

Specialist pharmaceutical concern Plethora Solutions Holdings (PLE) says it has won approval for its vaginal dryness treatment Hyalofemme from the NHS for prescription.

The agreement means that doctors in the UK will now be able to write prescriptions for Hyalofemme for the first time for atrophic vaginitis, commonly referred to as vaginal dryness. Traditional treatments involve the use of hormonal creams containing estrogen, but such creams are often inappropriate for cancer patients, who often suffer vaginal dryness as a side effect of cancer treatment.

Chairman Bill Robinson remarks the decision by the NHS should 'increase the commercial value of our pipeline by exploiting products secured last year'. He adds that the release of Hyalofemme is an 'important treatment' for atrophic vaginitis.

Following the announcement analysts at house broker Daniel Stewart held their forecasts of a year-end loss of £1.3 million (2010: loss of £1.5 million) on revenue up £100,000 to £1.2 million. They have pencilled in a loss per share of 2.5p for 2011 and a further loss of 3.4p a share for 2012.

Shares in Plethora were up 0.25p this morning following the announcement to 7.5p, the price at which Growth Company Investor recommended them earlier this month. A good sign for the company's prospects, Hyalofemme will be prescribed both for those being treated for cancer and women going through the menopause. We therefore reiterate our speculative buy rating.

Tags: AIM market, Menopause, Pharma, Plethora Solutions Holdings, Urology Company, Vaginal dryness

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Lower coal prices hit Hargreaves Services

Hargreaves hits year low on weak coal markets 02/07/2015

Hargreaves Services shares hit a new 52-week low after the company said it was suffering from weaker coal prices and other difficult trading conditions.

Sirius leaps on North York Moors project approval 01/07/2015

Sirius Minerals shares soared more than 60% on AIM today after the potash company got the go-ahead for a project in the North York Moors. 

Mixed bag for Plastics Capital  30/06/2015

In its results statement this morning, Plastics Capital said its revenue growth in the year to March was largely driven by acquisitions, including one that enabled the company to transform its operations in China.

Carpetright on sound footing  30/06/2015

Shares in Carpetright soared to their highest in more than a year after the floorings retailer ‘s results  impressed city analysts and it said current trading was also going well, 

Eden Research shares in bloom following regulatory boost  25/06/2015

The announcement this morning that Eden Research has been granted licences for a pair of the ingredients it has developed for use in its plant protection products has seen shares in the business surge ahead by more than 20 per cent this morning.

Management at REACT Energy vow to plough on despite entering 'examinership' 24/06/2015

The management team at AIM-listed Irish resources company REACT Energy informed the market today that they are confident they can secure financing, and the approval of shareholders and creditors, to continue as a going concern despite entering 'examinership'.

More News